• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

保留角膜上皮瓣的角膜胶原交联术治疗较薄型圆锥角膜的临床研究

The clinical study of corneal cross-linking with preserved corneal epithelial flap in thin keratoconic corneas

摘要:

目的 探讨保留角膜上皮瓣的角膜胶原交联术(CXL)治疗较薄型圆锥角膜眼的疗效和安全性.方法 前瞻性病例对照研究.收集自2013年9月至2014年3月于山东省眼科医院住院治疗的20例(22只眼)较薄型圆锥角膜患者(去除角膜上皮后角膜基质厚度<400μm),其中男性16例,女性4例;年龄(23.5±4.9)岁.CXL中应用等渗性核黄素后再进行紫外线照射.照射时将上皮瓣复位,治疗前及治疗后12个月检查视力和角膜内皮细胞计数,采用角膜地形图测量角膜厚度和角膜曲率.对治疗前后的各项数据进行配对t检验.结果 治疗前及治疗后12个月的所有患眼角膜厚度分别为(400.6±14.9)和(396.5±16.3)μm,角膜内皮细胞计数分别为(2824±308)和(2753±372)个/mm2,差异均无统计学意义(t=1.973,0.928;P>0.05).治疗前角膜最大曲率(Kmax)、角膜最小曲率(Kmin)、角膜前表面K值(Km)分别为(54.73±4.39)、(48.97±3.72)、(51.67±3.77)D,治疗后分别为(53.46±3.85)、(48.41±3.17)、(50.77±3.28)D,差异均有统计学意义(t=-3.138,-2.170,-3.532;P<0.05).所有患者治疗后均无角膜内皮失代偿、角膜瘢痕形成等并发症.患者视力经过治疗有所提高.结论 保留角膜上皮瓣的CXL治疗较薄型圆锥角膜,术后角膜地形图参数改善,角膜内皮细胞无损伤,无明显不良反应,提示该治疗方法安全、有效.

更多
abstracts:

Objective To evaluate the therapeutic effect of corneal collagen cross-linking (CXL) with preserved corneal epithelial flap and isotonic riboflavin for treatment of keratoconus eyes with thin corneas. Methods Prospective case-control study. Twenty two eyes of 20 patients (16 males and 4 females, with age of 23.5 ± 4.9), who have been diagnosed with progressive keratoeonus and the comeal stroma thickness of whom were less than 400μm (without the epithelium), were included in this study. Corneal collagen crosslinking was performed under preserved corneal epithelial flap (8.5mm), followed by instillation of 0.1% riboflavin and then UV irradiation. The corneal epithelial flap must be restored prior to the application of UVA irradiation. Visual acuity, corneal topography and endothelial cell count were evaluated at baseline and at 12 months follow-up. Data were analyzed using paired samples t test. Results Corneal topography results of 12m before and after the therapy revealed the significant reductions of Kmax from (54.73±4.39)D to (53.46±3.85)D and Kmin from (48.97±3.72)D to (48.41±3.17)D, and also Km from (51.67± 3.77) D to (50.77±3.28) D (Kmax:t=-3.138, P<0.05;Kmin:t=-2.170, P<0.05;Km:t=-3.532, P<0.05). No statistically significant differences were found between the average corneal thickness of pre therapy [(400.6± 14.9) μm] and post therapy [(396.5 ± 16.3)μm] (t=1.973, P>0.05). Endothelial cell counts of pre therapy [(2824±308)/mm2] and post therapy [(2753±372)/mm2] were of no statistical significance as well (t=0.928, P>0.05). No complications such as scarring lesions in the stroma and corneal endothelial damage were observed throughout the study period. Most of the patient's vision improved after treatment. Conclusion The application of isotonic ribonavin solution in a cross-linking procedure in thin corneas with preserved corneal epithelial flap seems to be safe and effective as keratoconus tend to be stable at 12 months after therapy and no endothelial cell damage was caused.

More
作者: 孙吉君 [1] 黄晓静 [1] 史伟云 [1] 王婷 [1]
期刊: 《中华眼科杂志》2018年54卷6期 421-425页 MEDLINEISTICPKUCSCD
栏目名称: 论著
DOI: 10.3760/cma.j.issn.0412-4081.2018.06.006
发布时间: 2018-07-11
基金项目:
山东省重点研发计划(2015GGH318010)Key R&D Project of Shandong Province
  • 浏览:435
  • 下载:468

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷